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Abstract. Serine proteinases of human polymorphonu- 
clear neutrophils play an important role in neutrophil- 
mediated proteolytic events; however, the non-oxidative 
mechanisms by which the cells can degrade extracellu- 
lar matrix in the presence of proteinase inhibitors have 
not been elucidated. Herein, we provide the first report 
that human neutrophils express persistently active cell 
surface-bound human leukocyte elastase and cathepsin 
G on their cell surface. Unstimulated neutrophils have 
minimal cell surface expression of these enzymes; how- 
ever, phorbol ester induces a 30-fold increase. While 
exposure of neutrophils to chemoattractants (fMLP 
and C5a) stimulates modest (two- to threefold) in- 
creases in cell surface expression of serine proteinases, 
priming with concentrations of lipopolysaccharide as 
low as 100 fg/ml leads to striking (up to 10-fold) in- 
crease in chemoattractant-induced cell surface expres- 
sion, even in the presence of serum proteins. LPS- 
primed and fMLP-stimulated  neutrophils have ~100 ng 
of cell surface human leukocyte elastase activity per 106 
cells. Cell surface-bound human leukocyte elastase is 
catalytically  active, yet is remarkably resistant to inhibi- 
tion by naturally occurring proteinase inhibitors. These 
data indicate that binding of serine proteinases to the 
cell surface focuses and preserves their catalytic activity, 
even in the presence of proteinase inhibitors. Upregu- 
lated expression of persistently active cell surface- 
bound serine proteinases on activated neutrophils 
provides a novel mechanism to facilitate their egress 
from the vasculature, penetration of tissue barriers, and 
recruitment into sites of inflammation. Dysregulation 
of the cell surface expression of these enzymes has 
the potential to cause tissue destruction during inflam- 
mation. 
C 
ONTROLLED proteolytic activity of human polymor- 
phonuclear neutrophils (PMN) 1  is involved in crit- 
ically important processes,  such  as  egress  of the 
cells from the vasculature and their penetration of tissue 
barriers (55). However, tissue destruction and a variety of 
disabling diseases result when proteolysis of extracellular 
matrix components by PMN is excessive, inappropriate, or 
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fluorescein isothiocyanate; fMLP, N-formyl-methionyl-leucyl-phenylala- 
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nyl-ala-ala-pro-val  chloromethylketone;  LDH,  lactate  dehydrogenase; 
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prolonged (2,  10, 37). Human leukocyte elastase  and ca- 
thepsin G are two serine proteinases contained within the 
azurophil granules of PMN that degrade a variety of extra- 
cellular  matrix macromolecules and play important roles 
in PMN-mediated proteolytic events. 
In contrast to the wealth of available information about 
the structure and biochemistry of proteinases and their in- 
hibitors, including the catalytic behavior of these enzymes 
when they are free in solution (15, 16, 35, 58, 59, 61-63), 
we have remarkably little information about the mecha- 
nisms by which PMN use and control their proteolytic en- 
zymes to degrade extracellular matrix proteins in vivo. It is 
clear that degradation of extracellular matrix proteins by 
PMN in vivo must occur in an extracellular milieu that is 
replete with high concentrations of numerous proteinase 
inhibitors (63), We (9, 11) and others (54) have found that 
proteinase inhibitors confine proteolytic activity of PMN 
to the immediate pericellular  microenvironment in vitro, 
but that they cannot inhibit degradation of proteins that 
are in direct contact with the cells. 
PMN may locally degrade matrix macromolecules in the 
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tion of proteinase inhibitors in the pericellular environ- 
ment.  Both reactive oxygen species  and  metalloprotein- 
ases have been shown to inactivate eq-proteinase inhibitor 
(13, 14, 22, 65) and other physiologic proteinase inhibitors 
(22, 23, 39, 53). PMN release oxidants locally at the site of 
their contact with a  surface (64), and activated PMN se- 
crete metalloproteinases (4,  24,  45). Thus, proteolysis in 
the  microenvironment surrounding  a  cell may be  facili- 
tated by local inactivation of proteinase inhibitors. 
Pericellular  proteolysis  by  PMN  may  also  proceed 
through modification(s) of the proteinases. We have con- 
sidered the possibility that the catalytic activities of human 
leukocyte elastase and cathepsin G  are focused and pro- 
tected when these enzymes are bound to the cell surface of 
PMN (10). 
Herein, we  report that  human  leukocyte elastase  and 
cathepsin  G  are  expressed on  the  cell surface  of PMN. 
These cell surface-bound enzymes are strikingly upregu- 
lated in activated PMN. Cell surface-bound human leuko- 
cyte elastase is catalytically active, and in marked contrast 
to  enzyme that  is  freely released  into  the  extracellular 
space,  membrane-bound  enzyme is remarkably resistant 
to inhibition by naturally occurring proteinase inhibitors. 
These observations indicate that PMN have the capacity 
to sharply focus the catalytic activity of human leukocyte 
elastase and cathepsin G, and provide a novel, non-oxida- 
tive mechanism by which the activity of these enzymes can 
be preserved in the presence of inhibitors. 
Materials and Methods 
Reagents 
Aurobeads (30 nm diam) were purchased from Amersham Corp. (Arling- 
ton Heights, IL). Hypaque was purchased from Winthrop-Breon Labora- 
tories, Sterling Drug Inc. (New York, NY). Rabbit anti-sheep F(ab)2 and 
rabbit anti-sheep F(ab)2 conjugated to FITC were obtained from Cappel 
(Malvern, PA).  IgG fractions of monospecific sheep anti-human leuko- 
cyte elastase and anti-cathepsin G were provided by Dr. D. Burnett (Uni- 
versity  of Birmingham, Birmingham, UK).  T-boc-ala-thiobenzyl ester, 
methyl-succinyl-phe-thiobenzyl ester,  and  Z-ala-ala-pro-aala-ONP were 
purchased from Enzyme Systems Products (Livermore, CA). Human se- 
rum albumin was obtained from the American Red Cross (Washington, 
DC). Permount was purchased from Fisher Scientific (Pittsburgh, PA). 
The limulus amebocyte lysate assay was purchased from Biowhittaker Inc. 
(Walkersville, MD). All other reagents were obtained from Sigma Chemi- 
cal Co. (St. Louis, MO). 
Serine Proteinases and Proteinase Inhibitors 
Human leukocyte elastase and cathepsin G  were purified from purulent 
sputum, as described previously (42). The human leukocyte elastase prep- 
aration was 98% active when titrated against the active site titrant Z-ala- 
ala-pro-aala-ONP (51). 
cq-proteinase inhibitor  was obtained  from Bayer  Corporation  (New 
Haven, CT). Eglin C was obtained from Dr. H. P. Schnebli (Ciba-Geigy 
Limited, Basel, Switzerland). Antileukoproteinase (ALP) was a gift from 
Dr. J. Kramps (University of Leiden, Leiden, The Netherlands). Secretory 
leukocyte proteinase inhibitor (SLPI) was provided by Dr. J. Hoidal (Uni- 
versity of Utah Health Sciences Center, Salt Lake City, UT). Methoxysuc- 
cinyl-ala-ala-pro-val chloromethylketone (HLE/CMK) and Z-gly-leu-phe 
chloromethyl ketone (CG/CMK) were purchased from Enzyme Systems 
Products (Livermore, CA). 
The activity of the al-proteinase inhibitor was measured using active 
site-titrated human leukocyte elastase (3), and was shown to be 44% ac- 
tive. All concentrations of HLE and arproteinase inhibitor indicated re- 
fer to the amount of active protein present. 
PMN Isolation 
Unless otherwise specified, human PMN were obtained from peripheral 
blood by ficoU-Hypaque and dextran sedimentation (5). Extreme care was 
taken to minimize endotoxin contamination in all reagents and buffers. 
For example, gloves were worn throughout the procedure, all glassware 
was baked at 180°C for 18 h, and cells were collected into sterile, endo- 
toxin-free polypropylene tubes. All buffers were assayed for endotoxin us- 
ing the amebocyte lysate method (36);  they contained endotoxin concen- 
trations that were below the lower limit of detection of the assay (3 pg/ml). 
Differential  counting was performed on  cytocentrifuge preparations 
(Cytospin  2,  Shandon  Southern  Instruments, Sewickley,  PA),  and  re- 
vealed that greater than 95% of the cells were PMN. The remainder of the 
cells were eosinophils. 
Where specified, PMN were also isolated by the plasma-Percoll gradi- 
ent  technique,  as  described  elsewhere  (32).  These  preparations  were 
greater than 95% pure. The remainder of the nucleated cells were eosino- 
phils. 
PMN Priming  and Stimulation 
PMN were resuspended at 2 ×  106/ml in HBSS, and then incubated for 5 
to 60 min at 37°C, with and without the following stimuli: (a)  phorbol 
myristate acetate (PMA, 50 ng/ml); (b) N-formyl-methionyl-leucyl-phenyl- 
alanine (fMLP, 10 -8 M); (c) complement component 5a (CSa, 10 -8 M); 
and (d) bacterial lipopolysaccharide from Escherichia  coli 0111:B4 (LPS, 
1 fg/ml to 100 ng/ml). Preliminary experiments established that the opti- 
mal incubation time for PMA and chemoanractants was 30 min, and this 
incubation time was used in all subsequent experiments. In additional pre- 
liminary experiments, we incubated PMN for 30 rain at 37°C with and 
without fMLP at 10 -~° to 10 -6 M to establish the optimal concentration of 
fMLP for use in subsequent experiments reported here. 
To assess the effect of priming PMN with LPS for subsequent stimula- 
tion with fMLP, cells were prewarmed to 37°C, and then incubated at 37°C 
for 5 min with varying concentrations of LPS. The cells were incubated for 
a further 30 rain at 37°C with fMLP (10 -8 M). To determine whether the 
stimuli adversely affected cell viability, cell-free supernatant fluids were 
harvested, extracts of unstimulated PMN were prepared in 0.05 M phos- 
phate buffer containing 0.04%  (vol/vol) Triton and 1 M  NaC1,  and sam- 
ples were analyzed for lactate dehydrogenase (LDH) activity using a com- 
mercially available kit (Sigma). The results for cell-free supernatant fluids 
were expressed as a percentage of the amount of LDH activity contained 
within extracts of PMN. 
Effect of Serum Proteins on Agonist-induced 
Upregulation of Cell Surface-bound Serine Proteinases 
PMN were resuspended at 4  ×  106 cells/ml in HBSS  or HBSS supple- 
mented with 20%  autologous serum, as a  source of naturally occurring 
proteinase inhibitors. Ceils were primed for 5 rain at 37°C with 10 pg/ml 
LPS then stimulated for 30 rain at 37°C with 10  -8 M fMLP. Control cells 
were incubated at 37°C in the absence of agonists. 
Binding of  Exogenous Serine Proteinases to PMN 
PMN were resuspended in HBSS at 107 cells/ml, then incubated for 30 min 
at 4°C with and without exogenous human leukocyte elastase and cathep- 
sin G  (1 p.g/106 cells). Cells were then washed with HBSS to remove un- 
bound proteinases. 
Immunofluorescence and Image Analysis 
PMN were fixed for 3 min at 4°C in PBS containing 3% (wt/vol) paraform- 
aldehyde and 0.25% (vol/vol) glutaraldehyde (pH 7.4), and then washed 
twice in HBSS. Cells (106) were incubated at 4°C in HBSS containing 1% 
(vol/vol) human serum albumin (pH 7.4) to reduce non-specific binding of 
antibodies. To stain for serine proteinases, the PMN were incubated for 45 
min at 4°C with sheep anti-human leukocyte elastase F(ab)2, sheep anti- 
cathepsin G F(ab)2 or non-specific sheep F(ab)2, and then washed twice to 
remove excess antibody.  Cells were  incubated for 45  min at  4°C with 
FITC-conjugated  rabbit  anti-sheep F(ab)2,  and  then  washed  twice  in 
HBSS. Cytocentrifuge preparations were mounted in 25% (vol/vol) glyc- 
erol  in PBS  containing 250  iJ,  g/ml p-phenylenediamine to  reduce  pho- 
tobleaching (47), and coverslips were applied. 
The immunostained cells were examined with phase--contrast and inci- 
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Leitz NPL Fluotar 40x, N.A. 1.32 objective; Leica Westlar GMBH). The 
cells were imaged with a  chilled charge-coupled device camera (Photo- 
metrics, Tucson, AZ) that was interfaced with a PC-compatible computer 
and  Metamorph  hardware/software  for  image  processing and  analysis 
(Universal Imaging, Inc., West Chester, PA). Images containing 15 to 25 
cells per microscopic field were captured, and background was subtracted 
from each image before analysis. Preliminary results indicated that back- 
ground subtraction yielded illumination intensities in the background with 
a coefficient of variation of ~0.4% over the microscopic field. For analy- 
sis, a region of interest was created that corresponded to each cell in the 
field. The integrated fluorescence intensity in the region of interest was 
calculated. For each cell analyzed, the integrated fluorescence intensity of 
an identical region of interest, located over an adjacent cell-free area of 
the  image, was  calculated  and  subtracted  from the  cell's fluorescence 
value. The fluorescence intensity of 100-150 cells in each group was quan- 
tified. To correct for non-specific staining, the mean fluorescence for the 
group of cells that were incubated with the non-specific sheep F(ab)2 was 
subtracted from each of the values for cells that were incubated with the 
specific antibodies. 
Immunogold Microscopy 
To confirm that the serine proteinase antigens observed by immunofluo- 
rescence were located on the cell surface of PMN, cells were labeled with 
the primary F(ab)2 antibodies, as described above, then incubated for 45 
min at 4°C with rabbit anti-sheep F(ab)2 that had been conjugated to col- 
loidal gold particles of 30 nm diameter, as recommended by the manufac- 
turer. The PMN were then washed twice in 0.25  M  Tris containing 1% 
(vol/vol) bovine serum albumin and 0.05%  (vol/vol) polyethylene glycol 
(pH 8.0). Cytocentrifuge preparations were mounted in Permount, cover- 
slips were applied, and the slides were examined with polarization reflec- 
tion microscopy (polarized incident light, when reflected from gold parti- 
cles, passes through the cross polarizer in the Leitz RK reflection contrast 
100X, N.A. 1.32 objective). 
Enzyme Histochemistry 
PMN were suspended at 2  x  106/ml in HBSS and stimulated for 20 min 
with fMLP (10 -8 M), and then fixed for 30 min with 2% glutaraldehyde 
buffered with 0.1 M cacodylate-HCl (pH 7.4). The cells were washed twice 
in HBSS and then incubated for 30 min at 37°C in 3 ml of 0.1 M Tris-HC1, 
pH 7.8, containing 2 mg sodium aurothiosulfate (gold sulfate) and 1 mg of 
either t-boc-ala-thiobenzyl ester or met-succ-phe-thiobenzyl ester, which 
are substrates that react with human leukocyte elastase and cathepsin G, 
respectively (19, 20, 56). As a control, cells were incubated in buffer con- 
taining gold sulfate without substrate or with CBZ-arg-thiobenzyl ester, 
which is not hydrolyzed by any known PMN proteases. The PMN were 
washed twice in HBSS and postosmicated for 60 min with 2% aqueous os- 
mium, followed by routine dehydration and embedding in low viscosity 
resin. Sections were examined and photographed with a Phillips 410 elec- 
tron microscope at 80 kV. 
Degradation of  Fibronectin by Cell 
Surface-bound Enzyme 
PMN were incubated for 5 min at 37°C with 10 pg/ml LPS, and then stimu- 
lated for 30 min with fMLP (10 -8 M). After stimulation, cells were fixed 
for 3 min at 4°C with PBS containing 3% (wt/vol) paraformaldehyde and 
1% (vol/vol) glutaraldehyde, washed twice in PBS, and resuspended at 4 x 
107/ml in PBS. Fixed PMN (2 x  106) or purified human leukocyte elastase 
(50 ng) were added to fibronectin (20 I~g) in the presence or absence of 
HLE/CMK or CG/CMK (60 ILM), then incubated for 3 h  at 37°C.  After 
centrifugation at 300 g for 5 min, the cell-free supernatant fluids were har- 
vested, reduced with 10% (vol/vol) 13-2 mercaptoethanol, and subjected to 
SDS-polyacrylamide electrophoresis (38). 
To exclude the possibility that cleavage of fibronectin by fixed PMN 
was due to release of human leukocyte elastase from intracellular gran- 
ules, cells were incubated under identical conditions (4 x  107/ml in PBS 
for 3 h  at 37°C). 200 ~1 aliquots of cell-free supernatant fluids were as- 
sayed in triplicate  for human leukocyte elastase activity using 100 ILM 
methoxysuccinyl-ala-ala-pro-val paranitroanilide  (MSAPN)  as  a  sub- 
strate. Absorbances were read at 410 nM with a  Vmax  Kinetic Microplate 
Reader (Molecular Devices Corp., Palo Alto, CA). The assay was sensi- 
tive to release of 0.5 ng of human leukocyte elastase activity per 106 PMN. 
Quantification of Cell Surface-bound Human 
Leukocyte Elastase 
To obtain an estimate of the amount of human leukocyte elastase activity 
that is bound to the cell surface of PMN, cells were primed with LPS, stim- 
ulated with fMLP, and then fixed for 3 min at 4°C with PBS containing 3% 
(wt/vol)  paraformaldehyde  and 0.25%  (vol/vol)  glutaraldehyde,  as  de- 
scribed above. Varying numbers of cells (5 x  103 to 5  x  104) or varying 
amounts of purified human leukocyte elastase (1 to 5 ng) were incubated 
for 3 h at 37°C with fibronectin (10 ILg). Cell-free supernatant fluids were 
harvested, then reduced  with  10%  (vol/vol)  13-2 mercaptoethanol,  and 
subjected  to  SDS-polyacrylamide  electrophoresis to  assess fibronectin 
degradation. 
To confirm that fixation of PMN does not affect the catalytic activity of 
cell surface-bound serine proteinases, PMN were fixed for 3 min with 3% 
(wt/vol)  paraformaldehyde and 0.25%  (vol/vol)  glutaraldehyde (to  pre- 
vent leakage of endogenous proteinases), then incubated with exogenous 
human leukocyte elastase as described above. PMN were washed in HBSS 
to remove unbound proteinase, then aliquots of cell suspension were ei- 
ther fixed for a second time (as above) or held in PBS alone. Both groups 
of cells were washed, resuspended at 4  x  106/ml in HBSS, and then as- 
sayed in triplicate (100 iLl/assay) for human leukocyte elastase activity us- 
ing MSAPN. 
Effect of  Proteinase Inhibitors on the Activity of Cell 
Surface Serine Proteinases 
PMN were resuspended at 4 x  106 cells/ml in HBSS and stimulated for 30 
min at 37°C with PMA (50 ng/ml) or fMLP (10 -8 M), after which, cells and 
cell-free  supernatant fluids were  harvested. The  cells were  fixed with 
paraformaldehye  and  glutaraldehyde  as  described  previously,  washed 
twice in PBS, then resuspended in PBS at 5 x  106 cells/ml. For assay, 100 
ILl of fixed cell suspension, cell-free supernatant fluid, or purified human 
leukocyte elastase (100 ng/assay) were dispensed into triplicate wells of a 
microtiter plate. 100 p~l of the following inhibitors (or 100 p,l of PBS, as a 
control) were  then dispensed into the wells: (a) cq-proteinase inhibitor 
(~q-PI, 25 ~g/ml); (b) eglin C (5 p.g/ml);  (c) antileukoprotease (ALP, 7.5 
ixg/ml);  (d) secretory leukocyte proteinase inhibitor (SLPI, 6 ILg/ml); (e) 
HLE/CMK  (60  ILM); (3') CG/CMK  (60  ~M);  (g)  N-a-p-tosyl-L-lysine- 
chloromethyl ketone (TLCK, 60 ixM); and (h) PMSF (1 mM). After pre- 
incubation at room temperature for 10 min, MSAPN (100 p.M) was added 
to each well, and absorbances were read at 410 nM with a Vm~ Kinetic Mi- 
croplate Reader (Molecular Devices Corp., Palo Alto, CA). 
To test the effects of fixation of PMN on the effectiveness of inhibitors 
against cell surface-bound serine proteinases, the cells were fixed with 
paraformaldehyde and glutaraldehyde (to prevent leakage of endogenous 
serine proteinases), washed, resuspended in HBSS at 2 x  107 cells/ml, and 
then  incubated  for  30  min  at  4°C  with  exogenous human  leukocyte 
elastase (1 ILg/106 cells). Cells were then washed to remove unbound pro- 
teinase, and resuspended at 5 x  106/ml in HBSS, without a further fixation 
step. Cells (100 ill) were assayed in triplicate for cell surface-bound hu- 
man leukocyte elastase activity using MSAPN (100 I~M) as a substrate and 
purified  HLE  as  the  standard,  as  described  above.  Human leukocyte 
elastase (1.6 pmol), or 5  x  105 cells having cell surface-bound elastase 
with equivalent activity, were pre-incubated in triplicate (10 min, 25°C, to- 
tal volume 150 ILl) with HLE/CMK (60 ILM), with varying concentrations 
of cq-proteinase inhibitor, or with HBSS as a control. Residual catalytic 
activity of human leukocyte elastase was then quantified using MSAPN 
(100 IxM). 
Statistics 
Data are expressed as mean -SEM or mean _SD. The results for paired 
and unpaired data were compared using the Mann-Whitney rank sum test 
for non-parametric data; P  values less than 0.05 were considered signifi- 
cant. 
Results 
Elastase and Cathepsin G Are Expressed on the 
Surface of  Human PMN 
PMN  were  exposed  to  fMLP  for 30  min,  fixed,  stained 
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cathepsin  G,  and  then examined by epifluorescence mi- 
croscopy. Focal fluorescence was detected on the surface 
of cells incubated with anti-human leukocyte elastase and 
anti-cathepsin G  F(ab):, but not on cells incubated with 
non-specific F(ab): indicating that fMLP-stimulated cells 
express both human  leukocyte elastase  and cathepsin G 
on their cell surface. 
Effect of  PMA and Chemoattractants on Cell 
Surface Expression of  Human Leukocyte Elastase 
and Cathepsin G by PMN 
To examine regulation of cell surface expression of elastase 
and cathepsin  G, cells were incubated for varying times 
with  and  without  phorbol  ester,  fMLP,  and  C5a.  Cells 
were then fixed, labeled with FITC for cell surface-bound 
elastase and cathepsin G, and then analyzed by quantita- 
,,¢-, 
I 
o 
x 
tJ 
C  Q 
O 
M 
800 
A 
800 
4OO 
2O0 
0  r-,-,  I~1 
UnMlmulated  5 
¢1 
¢1 
m 
I- 
¢i 
¢1 
Z 
2 
30 
Time  (rain) 
15 
NI 
1 
tive  fluorescence imaging.  Unstimulated  cells  expressed 
minimal quantities of cell surface human leukocyte elastase 
and cathepsin G (Fig. 1). Exposure to PMA increased cell 
surface  expression of human  leukocyte elastase  and  ca- 
thepsin G by PMN within 15 min (Fig. 1 A). A  maximum 
effect (30-fold increase) was  observed after exposure of 
PMN to PMA for 30 min. In contrast, exposure of PMN to 
optimal concentrations of fMLP and C5a for 30 to 60 min 
stimulated  statistically  significant  but  modest  (approxi- 
mately twofold) increases in cell surface expression of hu- 
man leukocyte elastase and cathepsin G (Figs. 1, B and C). 
To determine the optimal concentration of fMLP for in- 
ducing increased expression of cell surface serine protein- 
ases,  cells  were  exposed  to  varying  concentrations  of 
fMLP for 30 min. FMLP stimulated a dose-dependent in- 
crease in cell surface human leukocyte elastase (Fig. 1 D). 
The optimal concentration of fMLP was 10  -8 M, and this 
concentration  was  used  in  all  subsequent  experiments. 
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Figure 1.  Effect of PMA and chemoattractants on PMN cell surface expression of serine proteinases. PMN were incubated for 5 to 60 
min at 37°C with and without 50 ng/ml PMA (A), 10 -8 M fMLP (B), and 10  -8 M  C5a (C), and then fixed in PBS containing 3% (wt/vol) 
paraformaldehyde and 0.25%  (vol/vol) glutaraldehyde (pH 7.4). Cells were then stained with FITC for cell surface human leukocyte 
elastase (open bars) and cathepsin G (hatched bars). Fluorescence was quantified by image analysis, as described in Methods. Note that 
exposure of PMN to PMA induced striking increases (~30-fold) in expression of cell surface human leukocyte elastase and cathepsin G 
within 30 min, whereas the chemoattractants, whose effects are shown on different scales, induced modest (approximately twofold) but 
highly significant increases in the expression of these enzymes. Data are mean values +_ SEM; n  =  100 to 150 cells. *, P  <  0.05; **, P  < 
0.025; and ***, P  <  0.001, respectively, when compared to unstimulated cells. In D, PMN were incubated for 30 min at 37°C with and 
without varying concentrations of fMLP, and then fixed and stained with FITC for cell surface human leukocyte elastase, as described 
above. Note the dose-related and significant increase in cell surface serine proteinases, with a maximal effect at 10  -8 M  fMLP. *, indi- 
cates P  <  0.025; **, P  <  0.01; ***, P  <  0.1301 when compared to unstimulated cells. 
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surface expression of cathepsin G (not shown). 
To exclude the possibility that any low level endotoxin 
contamination in our ficoll-Hypaque PMN isolation pro- 
cedure could prime PMN for subsequent stimulation with 
chemoattractants, we compared PMN that had been iso- 
lated by the ficoll-Hypaque technique to cells  isolated by 
the plasma-Percoll method. PMN were incubated for 30 
min with fMLP, and then stained with FITC for cell sur- 
face human leukocyte elastase. The mean fluorescence sig- 
nal  of  cells  isolated  by  the  ficoll-Hypaque  technique 
(54,857  -+ SD 10,675)  was similar to that of cells isolated 
by the plasma-Percoll gradient method (58,338  -  25,261). 
Priming of PMN by LPS  for Subsequent Stimulation 
by Chemoattractant 
We examined the effect of LPS at concentrations ranging 
from 1 fg/ml to 100 ng/ml on PMN cell surface expression 
of serine proteinases. Exposure of PMN for 30 min to 100 
ng/ml of LPS induced modest increases in cell surface ex- 
pression of human leukocyte elastase (Fig. 2 A) and cathep- 
sin G  (Fig. 2 B). There was no clear relationship between 
LPS concentration (range  1 fg/ml to  100 ng/ml)  and  the 
quantity of surface-bound serine proteinases (not shown). 
In marked contrast to the effect of LPS alone, priming 
of PMN for 5 min with LPS followed by stimulation for 30 
min with fMLP induced striking increases in the quantity 
of cell surface human leukocyte elastase and cathepsin G 
when compared to cells  that were  incubated with fMLP 
alone (Figs.  2, A  and B). Priming of PMN with 100 ng/ml 
of LPS induced threefold increases in cell surface expres- 
sion of human leukocyte elastase  and cathepsin G  when 
compared to ceils that were incubated with fMLP alone, 
and  six-  to sevenfold increases  over unstimulated  PMN. 
Higher concentrations of LPS did not further increase the 
quantity of cell surface-bound enzymes (data not shown). 
The  most  striking  effect  was  observed  when  cells  were 
primed with 1 to 10 pg/ml of LPS, which consistently induced 
three- to fourfold increases in cell surface-bound human 
leukocyte elastase and cathepsin G compared to cells incu- 
bated with fMLP alone, and six- to tenfold increases over 
unstimulated PMN. 
The experiments shown in Fig. 2 used priming concen- 
trations of LPS that have been used in other studies  (31, 
32, 57). However, we were impressed that even the lowest 
concentration tested (1 pg/ml) had a strong priming effect. 
Thus, we tested lower concentrations of LPS. The priming 
effect of LPS was still  observed at a concentration of 100 
fg/ml; however, the effect was lost at lower concentrations 
(Fig. 3, A and B). 
Since stimulation of PMN in vivo occurs in a milieu con- 
taining proteinase  inhibitors  and  a  variety of other pro- 
teins,  we measured  cell surface-bound human leukocyte 
elastase on PMN that had been suspended in either buffer 
or buffer containing 20% autologous serum. The agonists 
induced striking  increases  in  cell  surface-bound enzyme 
whether the pericellular fluid contained serum proteins or 
not (Fig. 4). Interestingly, cells that were activated in the 
presence of serum expressed greater quantities of cell sur- 
face-bound human leukocyte elastase when compared to 
cells  that were activated in buffer alone (P <  0.001).  This 
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Figure 2.  Effect of LPS on cell surface expression of serine pro- 
teinases by PMN. PMN were unstimulated (open bars) or incu- 
bated for 30 min at 37°C with 10  -8 M fMLP or 100 ng/ml of LPS 
(hatched bars). To test the possibility that LPS primes PMN for 
subsequent stimulation with fMLP, cells were also incubated for 
5 min at  37°C with the  indicated  concentrations  of LPS, then 
stimulated with 10 -8 M fMLP (solid bars). PMN were then fixed, 
as described in Fig. 1, and then stained with FITC for cell surface 
human leukocyte elastase (A) and cathepsin G (B). Note that 1-10 
pg/ml and 100 ng/ml of LPS primed PMN for enhanced cell sur- 
face expression of both human leukocyte elastase and cathepsin 
G during subsequent fMLP exposure. This was a consistent ob- 
servation in cells from four different donors. Data are mean  ± 
SEM, n = 100 to 150 cells. *, indicates P < 0.02; and **, indicates 
P < 0.002 compared to unstimulated cells; ***, indicates P < 0.03; 
and ****, indicates P  <  0.001 when LPS-primed cells are com- 
pared to PMN incubated with fMLP alone. 
enhanced agonist activity may be related to the presence of 
LPS-binding protein in  serum,  which augments many of 
the biologic activities of LPS (66, 67, 69). 
To exclude adverse effects of the above stimuli on cell 
viability, PMN were primed for 5 min with 1 fg/ml to 100 
ng/ml LPS, then stimulated for 30 min with fMLP. Cell- 
free supernatant fluids were harvested, cell extracts of un- 
stimulated PMN were prepared, and both were analyzed 
for lactate dehydrogenase (LDH) activity. All of the su- 
pernatant fluids contained less than 6% of the LDH activ- 
ity that was contained within the corresponding PMN ex- 
tracts, indicating that the stimuli did not significantly affect 
cell viability. 
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Figure 3.  Optimal concentration of LPS for priming of PMN for 
stimulation with fMLP. PMN were unstimulated (open bars) or 
incubated at 37°C for 30 min with 10  -8 M fMLP or 10 pg/ml LPS 
(hatched bars). Cells were also incubated at 37°C for 5 min with 
the indicated concentrations of LPS, then stimulated for 30 min 
with 10  -8 M fMLP (solid bars). PMN were then fixed and stained 
with  FITC for human leukocyte elastase  (A) and cathepsin  G 
(B). Note that the priming effect of LPS is observed at concentra- 
tions of LPS as low as 100 fg/ml. The priming effect is lost at 
lower concentrations. Data are mean  -+ SEM, n  =  100 to 150 
ceils. *, indicates P < 0.001 compared to unstimulated cells; **, P 
<  0.004 and ***, P  <  0.001 compared to cells  incubated with 
fMLP alone. 
Immunogold Localization of Serine Proteinases to the 
Cell Surface of PMN 
To  exclude  the  possibility  that  our  immunofluorescence 
technique  was  detecting  intracellular  antigens,  we local- 
ized  human  leukocyte  elastase  and  cathepsin  G  immu- 
noreactivity  using  antibody conjugated  to  colloidal  gold 
particles of 30 nm diam, which are too large to penetrate 
cells. There was essentially a  complete lack of gold parti- 
cles associated with LPS-primed and fMLP-stimulated cells 
that were incubated with non-specific F(ab)2 (Fig. 5, A  and 
B). Unstimulated PMN incubated with anti-human leuko- 
cyte elastase F(ab)2 (Fig. 5, C and D) were not obviously 
different from cells that were incubated with non-specific 
antibody (Fig. 5  B).  In marked contrast, LPS-primed  and 
fMLP-stimulated  cells  that  were  incubated  with  anti- 
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Figure 4.  LPS and flV[LP upregulate cell surface expression of 
human  leukocyte  elastase  in  the  presence  of serum  proteins. 
PMN were resuspended in HBSS (open bars) or HBSS contain- 
ing 20% autologous serum (hatched bars). Cells were either un- 
stimulated or primed for 5 min at 37°C with 10 pg/ml LPS, then 
stimulated for 30 min at 37°C with 10  -8 M fMLP (LPS + fMLP). 
Data were acquired as in Fig. 1. Note that the agonists induced 
striking increases in cell surface-bound human leukocyte elastase 
both in the presence and absence of serum. Data are mean _  SEM, 
n  =  100 to 150 cells. Asterisk indicates P  <  0.001 compared to 
unstimulated cells. 
human leukocyte elastase F(ab)2 had numerous gold parti- 
cles localized to their cell surface (Fig. 5, E and F). 
When  unstimulated  PMN  were  incubated  with  anti- 
cathepsin  G  F(ab)2,  there was almost a  complete lack of 
gold particles associated with the cells (Fig. 6, A  and B). In 
marked  contrast,  LPS-primed  and  fMLP-stimulated  cells 
that were incubated with anti-cathepsin  G  F(ab)2 had nu- 
merous gold particles localized to their cell surface (Fig. 6, 
C and D). 
Confirmation of the Presence and Activity of Cell 
Surface Human Leukocyte Eiastase and Cathepsin G by 
Enzyme Histochemistry 
To further confirm that serine proteinases are present on 
the PMN cell surface  and to begin to test  the possibility 
that  cell  surface-bound  enzymes are  catalytically  active, 
fMLP-stimulated  PMN  were  fixed,  incubated  with  gold 
sulfate and synthetic substrates that react with human leu- 
kocyte elastase and cathepsin G, and then examined by elec- 
tron microscopy. Reaction product indicative of cathepsin 
G  (Fig. 7, A  and B) and human leukocyte elastase  (Fig. 7 
C)  activity was  located  within  azurophil  granules.  How- 
ever, reaction product of both enzymes was also clearly ev- 
ident on the cell surface. In sections that showed release of 
granules  at the cell surface, intense  surrounding reaction 
product strongly suggested local retention  of enzyme on 
the  plasma membrane.  These  ultrastructural  studies  con- 
firm not only the cell surface localization, but also catalytic 
activity of the cell surface-bound enzymes. Cytochemical 
control preparations that contained the gold sulfate with- 
out substrate  showed no reaction density  (Fig. 7  D) that 
resembled reaction product (Fig. 7, A-C). 
Exogenous Serine Proteinases Bind to PMN 
To provide further assurance that serine proteinases bind 
The Journal of Cell Biology, Volume 131, 1995  780 Figure 5.  Immunogold microscopy of human leukocyte elastase on the cell surface of PMN. PMN were unstimulated or primed with 10 
pg/ml LPS for 5 min at 37°C, and then incubated with 10 -s M fMLP for a further 30 min. Cells were fixed, and then incubated with anti- 
human leukocyte elastase F(ab)2 and immunogold as described in Materials and Methods. The cells have not been permeabilized, and 
the gold particles cannot enter the cells. Cytocentrifuge preparations were examined both by phase-contrast and reflection polarization 
microscopy. (A, C, and E) Phase-contrast microscopy; (B, D, and F) reflection polarization microscopy. In B, note the nearly complete 
Iack of gold particles in the preparation that was incubated with non-specific F(ab)2. D shows that unstimulated PMN incubated with 
anti-human  leukocyte elastase F(ab)z were not obviously different from cells incubated with non-specific  F(ab)2. In marked contrast, F 
shows  numerous gold particles localized  to the cell surface of LPS-primed and fMLP-stimulated PMN that were labeled with anti- 
human leukocyte elastase F(ab)2 when the equatorial plane of the cells is in focus. The slight contrast of the cells is due to the polariza- 
tion optics, and is present in specimens that have not been exposed to gold particles. 
Owen et al. Neutrophils Express Cell Surface Serine Proteinases  781 Figure 6.  Immunogold microscopy of cathepsin  G on the cell surface of PMN. Unstimulated or LPS-primed and fMLP-stimulated  PMN 
were fixed, then incubated with anti-cathepsin  G F(ab)2 and immunogold as described in Materials and Methods.  Cytocentrifuge  prepa- 
rations were examined both by phase-contrast and reflection polarization microscopy. (A and C) Phase-contrast microscopy; (B and D) 
reflection polarization  microscopy. In B note the almost complete lack of gold particles associated with unstimulated PMN. In marked 
contrast,  D shows that numerous gold particles were localized to the cell surface of LPS-primed and fMLP-stimulated  PMN that were 
labeled with anti-cathepsin  G F(ab)2. 
to the external plasma membrane, we tested the capacity 
of exogenous serine proteinases to bind to PMN. Cells that 
were exposed to exogenous human leukocyte elastase and 
cathepsin G  expressed strikingly greater quantities of en- 
zyme than cells that were incubated in the absence of ex- 
ogenous  serine  proteinases  (Fig.  8).  These  data  indicate 
that  serine proteinases can bind to  sites on the  external 
plasma membrane of PMN. 
Cell Surface Human Leukocyte Elastase Degrades an 
ExtraceUular Matrix Protein 
To determine whether cell surface-bound human leuko- 
cyte elastase has the capacity to degrade large molecular 
weight  components  of  the  extracellular  matrix,  LPS- 
primed and fMLP-stimulated PMN were fixed, and  then 
incubated for 3 h with a representative soluble extracellu- 
lar matrix protein (fibronectin) both in the presence and 
absence of HLE/CMK, a  specific inhibitor of human leu- 
kocyte elastase.  As  a  control,  fibronectin  was also  incu- 
bated with purified human leukocyte elastase. When the 
cells were incubated with fibronectin, complete degrada- 
tion of intact fibronectin was observed (Fig. 9 A, lane 2) 
leaving degradation products identical to those produced 
by purified human leukocyte elastase (Fig.  9 A, lane 3). 
Human  leukocyte  elastase  activity  was  not  detected  in 
cell-free supernatant fluids, indicating that the proteolytic 
activity was cell-associated and not due to the release of 
intracellular  human  leukocyte  elastase.  This  cell-associ- 
ated proteolytic activity was completely inhibited by HLE/ 
CMK (Fig. 9 A, lane 4), but not by CG/CMK, a specific in- 
hibitor of cathepsin G  (not shown). 
These data indicate that cell surface-bound human leu- 
kocyte elastase  has  the  capacity to  degrade  fibronectin, 
yielding  degradation  products  similar to  those  produced 
by purified human leukocyte elastase in solution. 
Quantification  of the Catalytic Activity of Human 
Leukocyte Elastase That Is Bound to the Surface of 
Primed and Stimulated PMN 
To obtain an estimate of catalytically active human leuko- 
cyte elastase that is bound to the cell surface of primed and 
stimulated PMN, varying numbers of fixed cells or varying 
amounts of purified human leukocyte elastase were incu- 
bated for 3 h with fibronectin, and then fibronectin degra- 
The Journal of Cell Biology,  Volume 131, 1995  782 Figure 7.  Serine proteinases expressed on the PMN cell surface are catalytically active. PMN were stimulated with fMLP for 20 min, and 
then fixed in 2% (wt/vol) glutaraldehyde and incubated for 30 rain at 37°C with substrates specific for cathepsin G (A and B) or human 
leukocyte elastase (C) and in buffer containing sodium aurothiosulfate (gold sulfate),  as detailed in Materials and Methods. As a con- 
trol, ceils were incubated with non-hydrolyzable substrate or substrate-free medium containing the same buffer and gold sulfate (D). 
Ceils were washed and postfixed in osmium for 60 min and embedded in low viscosity resin. Thin sections were then prepared for elec- 
tron microscopy, and were not counterstained. Electron-dense reaction product, indicative of human leukocyte elastase and cathepsin G 
activity,  is present in azurophil granules (arrows,  A-C), and on the external surface of the plasma membrane (arrowheads,  A-C). B 
demonstrates granule fusion/release at the cell surface and the retention of reaction product along the external surface of the plasma 
membrane (arrowheads).  Control specimens showed no visible contrasting densities (D). Bars, 1 Izm. 
dation was assessed by SDS-polyacrylamide electrophore- 
sis of cell-free supernatant fluids (Fig. 9 B). One nanogram 
of human leukocyte elastase  (lane 2) produced no degra- 
dation of fibronectin, whereas 3 ng (lane 3) and 5 ng (lane 
4) of human leukocyte elastase resulted in partial and sub- 
stantial  degradation  of  intact  fibronectin,  respectively. 
50,000 fixed cells (lane 7) produced a similar pattern of fi- 
bronectin degradation products as 5 ng of purified human 
leukocyte elastase. Thus, we can estimate that 106 primed 
and stimulated PMN express ~100 ng of human leukocyte 
elastase activity on their cell surface. 
Cell-free  supernatant  fluids were  also assayed for free 
human leukocyte elastase activity, as described in Materi- 
als  and Methods.  Human  leukocyte elastase  activity was 
not  detected  in  cell-free  supernatant  fluids,  which  con- 
firmed that the PMN-derived proteolytic activity was cell 
associated  and not due to the release  of intracellular  en- 
zyme. 
We considered  the possibility that fixation of PMN re- 
duces  the  catalytic  activity  of cell  surface-bound  serine 
proteinases, thereby resulting in an underestimation of the 
quantity  of cell  surface-bound  serine  proteinases  when 
fixed cells are studied.  PMN were fixed (to prevent leak- 
age  of  endogenous  proteinases),  incubated  with  exoge- 
nous human leukocyte elastase,  and then incubated in the 
presence  and  absence  of fixatives.  Catalytic  activity was 
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Figure 8.  Exogenous serine proteinases bind to the cell surface of 
PMN.  PMN  were  incubated for 30  min  at  4°C  in  the  absence 
(None) or presence of either human leukocyte elastase (Elastase, 
1  ixg/106 cells; left) or cathepsin G  (1  ixg/106 cells, right). Cells 
were washed, fixed, and then stained with FITC for human leu- 
kocyte elastase (left) or cathepsin G (right). Note that both exog- 
enous human leukocyte elastase and cathepsin G  bound readily 
to the cell surface of PMN. Data are mean values; error bars rep- 
resent SEM; n  =  100 to 150 cells. Asterisk indicates P  <  0.001 
compared to cells incubated without exogenous proteinase. 
quantified  using  MSAPN  as  a  substrate.  Cell  surface 
bound exogenous elastase that was not subjected to fixa- 
tion expressed similar catalytic activity when compared to 
exogenously added elastase that was fixed onto  the  cells 
(191.6  +  SD  4.5  ng/106  cells and  196.5  -  SD  2.8  ng/106 
cells, respectively). These data demonstrate that our fixa- 
tion procedure has no significant effect on the catalytic ac- 
tivity of cell surface-bound serine proteinases. 
Cell Surface Human Leukocyte Elastase and 
Cathepsin G Are Resistant to Inhibition by High 
Molecular Weight Inhibitors 
To  examine  inhibition of cell surface-bound  serine  pro- 
teinases, we investigated the effect of naturally occurring 
and synthetic proteinase inhibitors on the activity of PMN 
cell surface human leukocyte elastase. To maximize cell sur- 
face enzymes, PMN were stimulated with PMA and then 
fixed  with  paraformaldehyde  and  glutaraldehyde.  Cata- 
lytic activity of cell surface-bound human leukocyte elastase 
was measured with a synthetic peptide substrate (MSAPN). 
We compared the effect of each inhibitor on cell surface- 
bound human leukocyte elastase with its effect on purified 
human leukocyte elastase in solution and on human leuko- 
cyte elastase released into supernatant  fluids from stimu- 
lated PMN. The human leukocyte elastase inhibitors PMSF, 
HLE/CMK,  cq-PI, eglin C, ALP, and SLPI were fully ef- 
fective, at the concentrations tested, as inhibitors of puri- 
fied human leukocyte elastase and human leukocyte elastase 
in PMN supernatant fluids (Table I). By contrast, the CG/ 
CMK  and  the  trypsin-inhibitory  chloromethyl  ketone 
(TLCK) had little effect. 
cq-PI, the  most  potent  naturally occurring inhibitor of 
free  human  leukocyte  elastase, was  strikingly ineffective 
against PMN cell surface human  leukocyte elastase activ- 
ity (Table I). In marked contrast, the low molecular weight 
synthetic proteinase inhibitors, PMSF and HLE/CMK, in- 
hibited about 85 %  of cell surface human leukocyte elastase 
activity. ALP, SLPI and eglin C, which are of intermediate 
Figure 9.  Fibronectin degradation by cell surface-bound human 
leukocyte elastase. (A) Fibronectin degradation and the effects of 
proteinase inhibitors. PMN were primed with 10 pg/ml LPS for 5 
min at 37°C, incubated with 10  -8 M fMLP for a further 30 min, 
and  then  fixed.  PMN  (2  x  106) or purified human  leukocyte 
elastase (50 ng) were incubated for 3 h at 37°C with 20 Ixg of fi- 
bronectin both in the presence and  absence of HLE/CMK  (60 
IxM). Supernatant fluids were  reduced and  applied to  a  7.5  to 
15%  SDS polyacrylamide gel. Lane 1, fibronectin alone; lane 2, 
fibronectin  +  cells;  lane  3,  fibronectin  +  human  leukocyte 
elastase; lane  4,  fibronectin  +  cells  +  HLE/CMK;  lane 5,  fi- 
bronectin +  human leukocyte elastase +  HLE/CMK. Note that 
in the presence of PMN, there was complete degradation of the 
fibronectin substrate, and this proteolytic activity was completely 
inhibited by HLE/CMK. (B) Quantification of the amount of hu- 
man leukocyte elastase that is bound to the cell surface of primed 
and  stimulated PMN.  PMN  were  primed with LPS, stimulated 
with fMLP, then fixed. PMN (5 ×  103 to 5 ×  104) or purified hu- 
man leukocyte elastase (1-5 ng) were incubated for 3 h  at 37°C 
with  10 txg of fibronectin. Supernatant fluids were reduced and 
applied to 7.5% to 15% SDS polyacrylamide gel electrophoresis. 
Lane 1, fibronectin alone; lane 2, fibronectin +  1 ng of human 
leukocyte elastase; lane 3, fibronectin +  3 ng of human leukocyte 
elastase; lane 4, fibronectin +  5 ng of human leukocyte elastase; 
lane 5, fibronectin  +  5  ×  103  PMN;  lane 6,  fibronectin  +  104 
PMN; lane 7, fibronectin +  5 ×  104 PMN. Note that 5 ×  104 PMN 
express proteolytic activity against fibronectin similar to that of 5 
ng of purified human leukocyte elastase. 
molecular weight, inhibited ~50%  of cell surface human 
leukocyte elastase activity. Inhibitors of cathepsin G  and 
trypsin (CG/CMK and TLCK) had minimal effect. 
We considered the possibility that exposure of PMN to 
fixatives reduces the effectiveness of high molecular weight 
proteinase inhibitors against cell surface-bound serine pro- 
teinases. PMN were fixed (to prevent leakage of endoge- 
nous  proteinases), washed in HBSS, then  incubated with 
exogenous human leukocyte elastase in the absence of fix- 
atives. We compared the capacity of HLE/CMK and vary- 
ing concentrations of al-proteinase inhibitor to inhibit pu- 
rified human  leukocyte  elastase  and  cell surface-bound, 
unfixed,  exogenously  added  human  leukocyte  elastase. 
Fig. 10 shows that while the HLE/CMK was slightly more 
effective against HLE in solution than against cell surface- 
bound  enzyme, it almost completely inhibited both  puri- 
fied  human  leukocyte  elastase  and  unfixed  exogenously 
added enzyme that was bound to the cell surface of PMN. 
As expected, cq-proteinase inhibitor was  an  effective in- 
hibitor against purified human leukocyte elastase, even at 
The Journal of Cell Biology, Volume 1_3 l, 1995  784 % Inhibition (+ S.DJ 
100 
Inhibitor  Fixed PMN  HLE (100 rig)  PMN supernatant* 
PMSF (1raM)  85 _+  13'  96 _+ 4  100 
HLE/CMK (60 aM)  86 _+  10  98 _+ 4  100 
CG/CMK (60 e~M)  10±  11  18--9  25_+3 
TLCK (60aM)  15 _+  10  5  _+ 5  10 _+  14 
c~IpI (25 fxg/ml)  14 _+  12  98 +  3  100 
Eglin C (5 Ixg/ml)  45 +  18  100  100 
ALP (7.5  Ixg/rnl)  57 -+ 6  100  100 
SLPI (6 Ixg/ml)  50 -+  18  100  100 
*  Cell-free supemate from phorbol-stimulated PMN. 
~n = 3-24 assays per condition tested. 
a 1:1 molar ratio. In marked contrast, cq-proteinase inhibi- 
tor was only partially effective against unfixed exogenous 
cell  surface-bound human leukocyte elastase  even when 
the inhibitor was added in lO0-fold molar excess over the 
quantity of active human leukocyte elastase that was bound 
to the cell surface of PMN. 
Together, these data indicate human leukocyte elastase 
that is bound to the cell surface of PMN in vivo is catalyti" 
cally active, yet substantially resistant to inhibition by nat- 
urally occurring proteinase inhibitors. 
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Figure 10.  Susceptibility of unfixed cell surface-bound  human 
leukocyte  elastase  to inhibition  by proteinase  inhibitors.  PMN 
were fixed, then incubated for 30 rain at 4°C with exogenous hu- 
man leukocyte elastase (1  ~g/106 cells). The quantity of human 
leukocyte elastase that bound to the cell surface was quantified 
using MSAPN, as described  in Methods. These  cells (5  ×  105, 
open bars), or soluble human leukocyte elastase having equiva- 
lent catalytic activity (1.6 pmol, hatched bars) were then assayed 
in triplicate for human leukocyte elastase activity after pre-incu- 
bation with varying amounts  of cq-proteinase inhibitor  ranging 
from equimolar to 100-fold excess. For comparison, inhibition of 
soluble (solid bars) and cell surface-bound  (cross-hatched bars) 
elastase by HLE/CMK  (60 p~M) is also shown. Note that HLE/ 
CMK almost completely inhibited both purified human leukocyte 
elastase and exogenous enzyme that was bound to the surface of 
PMN. cq-proteinase inhibitor was an effective inhibitor of puri- 
fied human  leukocyte  elastase, but  was only partially effective 
against unfixed exogenous enzyme that was bound to the surface 
of PMN, even when present in substantial molar excess. Data are 
mean values; error bars represent SD. 
Herein,  we  report  that  human  leukocyte  elastase  and 
cathepsin  G  are  expressed  on the cell  surface of human 
PMN. In addition, we have shown that cell surface expres- 
sion of elastase and cathepsin G can be strikingly upregu- 
lated by pro-inflammatory mediators. Cell surface-bound 
enzymes are catalytically active against a physiologic high 
molecular weight substrate,  as well as peptide substrates. 
However, in marked contrast to soluble  elastase  and ca- 
thepsin G, cell surface-bound enzymes are remarkably resis- 
tant to inhibition by naturally occurring proteinase inhibi- 
tors. Our data indicate that binding of serine proteinases 
to the PMN cell surface focuses and preserves their cata- 
lytic activity even in the presence of proteinase inhibitors. 
Regulation of the Expression of Cell Surface-bound 
Serine Proteinases 
We found minimal expression of serine proteinases on un- 
stimulated PMN; however, phorbol ester rapidly induced a 
30-fold increase  in  PMN cell  surface expression  of both 
human leukocyte elastase and cathepsin G. Although phor- 
bol ester induced dramatic increases in cell surface expres- 
sion of human leukocyte elastase and cathepsin G, phorbol 
ester effects are not directly relevant to human inflamma- 
tory processes in vivo. To evaluate more biologically rele- 
vant  agonists,  we  exposed  PMN  to  concentrations  of 
chemoattractants that are optimal for the chemotactic re- 
sponses, as well as to LPS. FMLP induced modest but sta- 
tistically significant  (approximately twofold) increases  in 
expression of these enzymes, but a wide range of concen- 
trations of LPS (1 fg/ml to 100 ng/ml) had minimal effect 
when used alone. 
In contrast to its minimal effect when used alone, LPS 
exerted  a striking priming effect on PMN for subsequent 
responses to chemoattractants. For example, LPS-primed 
and  fMLP-stimulated cells  expressed  6-  to  10-fold more 
human leukocyte elastase and cathepsin G on the cell sur- 
face than unstimulated cells.  Moreover, these agonists in- 
duced striking upregulation of cell surface-bound human 
leukocyte elastase, even in the presence of naturally occur- 
ring proteinase inhibitors. 
The priming effect of LPS was apparent with concentra- 
tions of LPS (10-100 ng/ml) that have been  reported  to 
prime PMN for other responses, such as release of reactive 
oxygen species  (31)  and  lysosomal enzymes (32).  How- 
ever,  the  dose-response  of the  LPS  priming  effect  was 
consistently biphasic,  with  a  striking  priming  effect  also 
apparent at concentrations of LPS in the range of 100 fg- 
10 pg/ml. We have also shown that priming of PMN with 
other pro-inflammatory mediators (platelet activating fac- 
tor and tumor necrosis factor-s), followed by stimulation 
with fMLP, induces striking increases in cell surface serine 
proteinases; however, the priming effects of these agonists 
do not exhibit a biphasic dose-response relationship (Owen, 
C. A., submitted for publication). 
The  mechanism(s)  underlying  the  biphasic  dose  re- 
sponse to LPS priming are unclear and are under investi- 
gation in this laboratory. However, we have been unable 
to find other studies that tested LPS concentrations in the 
lowest ranges that were effective in  our hands.  It is thus 
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responses as well. 
The mechanisms underlying priming of PMN by LPS have 
not been completely elucidated. However, priming of PMN 
by LPS is mediated by binding of LPS to CD14 receptor 
(67-69).  The  exact  signal  transduction  mechanisms  for 
LPS priming of PMN remain unclear. Binding of LPS to 
PMN has been variably reported to be associated with: (a) 
increases in intracellular calcium concentrations (30, 70); 
(b) translocation of a guanine-nucleotide binding protein 
to the plasma membrane (68); (c) increased activity of in- 
tracellular kinases resulting in phosphorylation of proteins 
that  are  involved in  cellular activation  (25,  60);  (d)  in- 
creased activity of phospholipases (25, 29); and (e) upregu- 
lation of fMLP receptor number (34, 66). 
Localization of Serine Proteinases to the Cell Surface 
of  PMN 
We confirmed that our quantitative immunofluorescence 
studies detected serine proteinases on the cell surface of 
PMN, rather than intracellular enzyme, by localizing hu- 
man leukocyte elastase  and cathepsin G  antigens  to the 
cell surface with immunogold particles that are too large 
to penetrate cells. Ultrastructural enzyme histochemistry 
demonstrated both cell surface localization and catalytic 
activity of human leukocyte elastase and cathepsin  G  in 
chemoattractant-stimulated cells (in addition to showing 
dense reaction product in azurophil granules). A previous 
report of ultrastructural histochemistry of elastase-like en- 
zymes (20) studied only unstimulated PMN, and did not 
detect cell surface reaction product. 
Mechanisms of  Binding of Serine Proteinases to the 
Cell Surface of PMN 
The histochemical studies suggested a mechanism for load- 
ing of the enzymes onto the cell membrane, in that dense 
reaction product decorated the cell surface regions around 
granules that were in the process of being released. Al- 
though we cannot exclude the possibility that a proportion 
of the serine proteinases are bound to the limiting mem- 
brane of the granules, which then becomes fused with the 
surface membrane  upon granule extrusion, our working 
hypothesis is that high local concentrations of the enzymes 
load human leukocyte elastase and cathepsin G onto bind- 
ing sites on the surface membrane. This possibility is sup- 
ported by our observation that exogenous serine protein- 
ase bind readily to sites on the external plasma membrane 
of PMN. In this regard, it is noteworthy that "receptors" 
for human leukocyte elastase have been reported on the 
cell surface of PMN (26). The reported human leukocyte 
elastase binding sites were numerous (>106 sites/cell) but 
displayed low-affinity binding characteristics (26). If con- 
firmed, such low-affinity/high capacity binding sites would 
be ideally suited to allow substantial amounts of cell sur- 
face binding of human leukocyte elastase in regions sur- 
rounding the high concentrations (millimolar range of en- 
zyme) present at sites of degranulation (8). Interestingly, 
binding of exogenously added human leukocyte elastase 
has been found to be reduced after exposure of PMN to 
phorbol ester (26), an effect that would be expected after 
occupation of cell surface binding sites by endogenous hu- 
man leukocyte elastase released during degranulation of 
the cells. 
It is possible that the mechanism of membrane binding 
is  predominantly  electrostatic,  since  serine  proteinases 
have a highly positive charge at physiologic pH. This possi- 
bility is supported by our preliminary findings that expo- 
sure of PMN to other highly positively charged molecules 
such as lactoferrin, protamine  and L-lysine almost com- 
pletely inhibits the increased expression of cell surface hu- 
man leukocyte elastase that is induced by LPS priming fol- 
lowed by fMLP stimulation, whereas negatively charged 
molecules are ineffective (Owen, C. A., unpublished ob- 
servations). 
The relationship of binding sites for human  leukocyte 
elastase on PMN to those that we and others have described 
on macrophages (7, 12, 43) and monocytes (43) remains 
open to investigation. However, such receptors are simi- 
larly low in affinity (2-4 X 10 -7 M), yet numerous (54-73 
x  106 sites per cell). In addition, the macrophage receptor 
has been shown to bind  both human  leukocyte elastase 
and cathepsin G, as well as lactoferrin, another azurophil 
granule constituent (7). It is also noteworthy that elastase- 
like proteinases have been found on the surface of periph- 
eral blood monocytes (40, 41, 71). 
Confirmation that Cell Surface-bound Serine 
Proteinases Are Catalytically  Active 
Catalytic activity of cell surface-hound human leukocyte 
elastase was confirmed by the synthetic substrate MSAPN. 
In addition, cell surface-bound human leukocyte elastase 
was  active against  a  large molecular weight polypeptide 
substrate that is an important component of the extracellu- 
lar matrix. When LPS-primed and fMLP-stimulated PMN 
were fixed, and then exposed to soluble fibronectin, frag- 
ments characteristic of human leukocyte elastase activity 
on SDS-polyacrylamide gel electrophoresis were produced. 
Proteolysis of fibronectin by fixed PMN was mediated by 
cell surface-bound human leukocyte elastase since: (a) it 
was completely inhibited by a specific inhibitor of human 
leukocyte elastase but not by a specific inhibitor of cathep- 
sin G; and (b) it could not be attributed to free human leu- 
kocyte elastase  activity released from the cells.  In  addi- 
tion, we have demonstrated that human leukocyte elastase 
activity persists on the cell surface for at least 3 h when vi- 
able cells are incubated at 37°C following cellular activa- 
tion (Owen, C. A., manuscript in preparation). Together, 
these  data  indicate  that  activated  PMN  express  persis- 
tently active serine proteinases on their cell surface that 
are  accessible  to  both  natural  and  synthetic  substrates. 
Moreover, we have obtained an estimate of catalytic hu- 
man leukocyte elastase that is cell surface-bound by com- 
paring the capacity of varying numbers of fixed cells or pu- 
rified human  leukocyte elastase  to degrade  fibronectin. 
We have estimated that 106 LPS-primed and fMLP-stimu- 
lated PMN express ~100 ng of human leukocyte elastase 
activity which is equivalent to the activity of ~10% of the 
total amount of enzyme that is contained within PMN. Ar- 
tifacts caused by fixation of the cells were excluded, in that 
exogenously added  enzyme,  whether  fixed  on  not,  ex- 
pressed similar catalytic activity. 
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Is Substantially Resistant to Inhibition by Naturally 
Occurring Proteinase Inhibitors 
Inhibitors of human leukocyte elastase that were fully ef- 
fective against  both purified enzyme and soluble human 
leukocyte elastase  released  from stimulated  PMN  were 
much less effective against human leukocyte elastase bound 
to the cell surface. The most striking example of this effect 
was  seen with Ctl-proteinase inhibitor. This serpin is  the 
most potent known inhibitor of human leukocyte elastase 
(1),  and  ~i-proteinase  inhibitor  interaction with  human 
leukocyte elastase has the highest reported association con- 
stant for an inhibitor with a proteinase (K~  .... ~  6.5 x  107); 
however, al-proteinase inhibitor was ineffective as an in- 
hibitor of cell surface-bound human  leukocyte elastase. 
When we tested inhibitors with a range of molecular sizes, 
there was  an inverse relationship between the molecular 
size of the inhibitor and its capacity to inhibit human leu- 
kocyte elastase  activity. Low molecular weight synthetic 
inhibitors  such  as  PMSF  and  HLE/CMK  substantially 
inhibited  cell surface  human  leukocyte elastase  activity, 
whereas inhibitors of intermediate size (ALP and SLPI) 
showed intermediate effectiveness. Because of the strong 
inverse relationship between molecular weight of inhibitors 
and their capacity to inhibit cell surface serine proteinases, 
it is likely that steric hindrance is the major mechanism by 
which cell surface-bound serine proteinases evade inhibi- 
tion. 
We were unable to test ct2-macroglobulin, the other ma- 
jor circulating inhibitor of human leukocyte elastase, be- 
cause its mechanism of inhibition (entrapment of enzymes) 
leaves the  enzymes active against  low molecular weight 
substrates such as MSAPN  (63). However, its very large 
size (725 kD)  argues that it would be ineffective against 
cell surface bound enzymes. 
Relationship to Other Cell Surface-bound Enzymes 
Our study is the first to report that human leukocyte elastase 
and cathepsin G are expressed on the cell surface of PMN. 
In other cellular systems, surface-bound proteinases have 
been  reported  (18).  For  example,  urokinase  type  plas- 
minogen activator and plasmin are expressed on the cell 
surface of fibroblasts and mononuclear cells (17, 27,  48- 
50). It has been hypothesized that cell surface-bound u-PA 
and plasmin are ideally suited to facilitate cell migration 
through fibrin clots and tissue barriers. Priming of PMN 
with tumor necrosis factor-et followed by stimulation with 
interleukin-8  induces  translocation  of  immunoreactive 
proteinase 3 from intracellular granules to the cell surface 
(21). Matrix metalloproteinases and cathepsin B  exist in 
catalytically active form on cell surfaces (6, 44, 46); more- 
over, cell surface binding is a proposed mechanism for ac- 
tivation of latent metalloproteinases (44, 46). 
Catalytically active alkaline phosphatase has been found 
to remain locally associated with the PMN cell membrane 
following specific granule release (33), and another gran- 
ule constituent, lactoferrin, has been found on the cell sur- 
face of even unstimulated PMN (28). In addition, it has 
been  reported that myeloperoxidase and  lactoferrin ap- 
pear locally on the surface of PMN as early as 5 s following 
phagocytic challenge (52). While these latter granule con- 
stituents are not proteinases, it is clear that they very rap- 
idly appear, and remain, on the cell surface of PMN fol- 
lowing degranulation. 
Conclusions 
We have shown  that  human  PMN  express cell surface- 
bound human leukocyte elastase and cathepsin G. More- 
over, we have demonstrated that cell surface-bound elastase 
and cathepsin G  are: (a) subject to regulation by physio- 
logically important mediators that are released from sites 
of inflammation;  (b)  upregulated on the  cell surface of 
PMN even in the presence of serum proteins; (c) accessi- 
ble to and catalytically active against even large molecular 
weight substrates; and (d) substantially resistant to inhibi- 
tion by naturally occurring proteinase inhibitors. Human 
leukocyte elastase, in particular, confers upon PMN the 
potential for powerful pro-inflammatory and matrix de- 
grading capacity through its ability to degrade a spectrum 
of matrix components (2). Our evidence suggests that cat- 
alytic activity of these enzymes can be sharply focused by 
cell surface binding. This work also provides a novel, non- 
oxidative mechanism of preserving the catalytic activity of 
human leukocyte elastase and cathepsin G in the presence 
of extracellular proteinase inhibitors. Long-lived catalyti- 
cally active cell surface-bound proteinases of PMN can fa- 
cilitate their egress from the vasculature, facilitate pene- 
tration of tissue barriers, and/or allow local degradation of 
extracellular matrix proteins with  minimal  injury to  the 
surrounding  tissue.  However,  excessive  upregulation  of 
the expression of cell surface-bound serine proteinases, such 
as may occur during endotoxemia, could contribute to the 
pathogenesis of inflammatory diseases associated with con- 
siderable morbidity and mortality. 
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